Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Benufutamab (GEN1029), a death receptor 5 (DR5)-specific agonistic antibody, comprises a blend of two non-competing DR5-specific IgG1 antibodies with an E430G mutation in the Fc domain. This compound exhibits antitumor effects [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Benufutamab (GEN1029), a death receptor 5 (DR5)-specific agonistic antibody, comprises a blend of two non-competing DR5-specific IgG1 antibodies with an E430G mutation in the Fc domain. This compound exhibits antitumor effects [1]. |
Molecular Weight | N/A |
CAS No. | 2109730-69-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Benufutamab 2109730-69-8 inhibitor inhibit